Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease

British Journal of Cancer

Volumn 102, Issue 4, 2010, Pages 748-753

  Behboudi, S ^a   Alisa, A ^a   Boswell, S ^a   Anastassiou, J ^a   Pathan, A A ^b   Williams, R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

AFP; Child Pugh; HCC; IFN producing cells; Okuda; Stage of disease

Indexed keywords

ALPHA FETOPROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CANCER STAGING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NEOPLASM STAGING; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; UP-REGULATION;

EID: 76949094210     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605526     Document Type: Article

References (22)

1. Alisa A, Boswell S, Pathan AA, Ayaru L, Williams R, Behboudi S (2008) Human CD4+ T cells recognize an Epitope within \{alpha\}-fetoprotein sequence and develop into TGF-\{beta\}-producing CD4+ T cells. J Immunol 180: 5109-5117
2. Alisa A, Ives A, Pathan AA, Navarrete CV, Williams R, Bertoletti A, Behboudi S (2005) Analysis of CD4+ T-cell responses to a novel \{alpha\}-fetoprotein-derived epitope in hepatocellular carcinoma patients. Clin Cancer Res 11: 6686-6694
3. Ayaru L, Pereira SP, Alisa A, Pathan AA, Williams R, Davidson B, Burroughs AK, Meyer T, Behboudi S (2007) Unmasking of \{alpha\}-fetoprotein- specific CD4+ T-cell responses in hepatocellular carcinoma patients undergoing embolization. J Immunol 178: 1914-1922
4. Bei R, Budillon A, Reale MG, Capuano G, Pomponi D, Budillon G, Frati L, Muraro R (1999) Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients. Cancer Res 59: 5471-5474
5. Butterfield LH, Koh A, Meng W, Vollmer CM, Ribas A, Dissette V, Lee E, Glaspy JA, McBride WH, Economou JS (1999) Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein. Cancer Res 59: 3134-3142
6. Butterfield LH, Meng WS, Koh A, Vollmer CM, Ribas A, Dissette VB, Faull K, Glaspy JA, McBride WH, Economou JS (2001) T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein. J Immunol 166: 5300-5308
7. Butterfield LH, Ribas A, Potter DM, Economou JS (2007) Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer. Cancer Immunol Immunother 56: 1931-1943
8. Capurro M, Filmus J (2005) Glypican-3 as a serum marker for hepatocellular carcinoma. Cancer Res 65: 372; author reply 372-373
9. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA (2001) Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97: 3146-3151
10. Evdokimova VN, Liu Y, Potter DM, Butterfield LH (2007) AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients. J Immunother 30: 425-437
11. Gehring AJ, Ho ZZ, Tan AT, Oo Aung M, Lee KH, Tan KC, Lim SG, Bertoletti A (2009) Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 137(2): 682-690
12. Grimm CF, Ortmann D, Mohr L, Michalak S, Krohne TU, Meckel S, Eisele S, Encke J, Blum HE, Geissler M (2000) Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice. Gastroenterology 119: 1104-1112
13. Kittaka N, Takemasa I, Takeda Y, Marubashi S, Nagano H, Umeshita K, Dono K, Matsubara K, Matsuura N, Monden M (2008) Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data. Eur J Cancer 44: 885-897
14. Liu Y, Daley S, Evdokimova VN, Zdobinski DD, Potter DM, Butterfield LH (2006) Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer. J Immunol 177: 712-721
15. Meng WS, Butterfield LH, Ribas A, Heller JB, Dissette VB, Glaspy JA, McBride WH, Economou JS (2000) Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein. Mol Immunol 37: 943-950
16. Mizejewski GJ (2007) Physiology of alpha-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome. Exp Biol Med (Maywood) 232: 993-1004
17. Mizukoshi E, Nakamoto Y, Tsuji H, Yamashita T, Kaneko S (2005) Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma. Int J Cancer 118(5): 1194-1204
18. Ritter M, Ali MY, Grimm CF, Weth R, Mohr L, Bocher WO, Endrulat K, Wedemeyer H, Blum HE, Geissler M (2004) Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma. J Hepatol 41: 999-1007
19. Shang XY, Chen HS, Zhang HG, Pang XW, Qiao H, Peng JR, Qin LL, Fei R, Mei MH, Leng XS, Gnjatic S, Ritter G, Simpson AJ, Old LJ, Chen WF (2004) The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients. Clin Cancer Res 10: 6946-6955
20. Thimme R, Neagu M, Boettler T, Neumann-Haefelin C, Kersting N, Geissler M, Makowiec F, Obermaier R, Hopt UT, Blum HE, Spangenberg HC (2008) Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T-cell responses in patients with hepatocellular carcinoma. Hepatology 48: 1821-1833
21. Um SH, Mulhall C, Alisa A, Ives AR, Karani J, Williams R, Bertoletti A, Behboudi S (2004) Alpha-fetoprotein impairs APC function and induces their apoptosis. J Immunol 173: 1772-1778
22. Whelan KT, Pathan AA, Sander CR, Fletcher HA, Poulton I, Alder NC, Hill AV, McShane H (2009) Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A. PLoS One 4: e5934